Concepedia
Statistics
Publications
4
Citations
2K
H-Index
Active since
2020
Affiliations
Peking University(Current)
Peking University International Hospital
Peking University First Hospital
Ezhou Central Hospital
Shenzhen Third People’s Hospital
Chi Zhang is an author at Peking University specializing in infectious diseases, pharmacotherapy, and inflammation.
Publications per year
2020–2022
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang, Zhao Wu, Jiawen Li et al. · International Journal of Antimicrobial Agents · 2020 · 1.8K citations · Full text
Life Sciences, Immunology, Infectious Diseases +14
Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size
Hong Zhao, Qi Zhu, Chi Zhang et al. · Biomedicine & Pharmacotherapy · 2020 · 107 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +11
Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial
Hong Zhao, Chi Zhang, Qi Zhu et al. · International Immunopharmacology · 2021 · 43 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +13
An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir
Yiqi Liu, Chi Zhang, Jiawen Li et al. · Journal of Clinical and Translational Hepatology · 2022 · 17 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
1–4 of 4